Ashfaq A Parkar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 3

Top Venues

British journal of clinical pharmacology

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Luc Bergougnan, Grit Andersen, Leona Plum-Mörschel, Maria Francesca Evaristi, Bruno Poirier, Agnes Tardat, Marcel Ermer, Theresa Herbrand, Jorge Arrubla, Hans Veit Coester, Roberto Sansone, Christian Heiss, Olivier Vitse, Fabrice Hurbin, Rania Boiron, Xavier Benain, David Radzik, Philip Janiak, Anthony J Muslin, Lionel Hovsepian, Stephane Kirkesseli, Paul Deutsch, Ashfaq A Parkar
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial. British journal of clinical pharmacology 87 (5) (2020)
Bruno Poirier, Veronique Briand, Dieter Kadereit, Matthias Schäfer, Paulus Wohlfart, Marie-Claire Philippo, Dominique Caillaud, Laurent Gouraud, Patrick Grailhe, Jean-Pierre Bidouard, Marc Trellu, Anthony J Muslin, Philip Janiak, Ashfaq A Parkar
A G protein-biased S1P1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Science signaling 13 (634) (2020)
Luc Bergougnan, Sara Armani, Georg Golor, Agnes Tardat, Olivier Vitse, Fabrice Hurbin, Michel Scemama, Franck Poitiers, David Radzik, Christophe Gaudin, Lionel Hovsepian, Anthony J Muslin, Stephane Kirkesseli, Paul Deutsch, Ashfaq A Parkar
First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection. British journal of clinical pharmacology 87 (2) (2020)

Ashfaq A Parkar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ashfaq A Parkar